Sadness in the SUN: Using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the united states

AIDS Patient Care and STDs

Volumn 26, Issue 12, 2012, Pages 718-729

  Tedaldi, Ellen M ^a   Van Den Berg Wolf, Mary ^a   Richardson, James ^b   Patel, Pragna ^c   Durham, Marcus ^c   Hammer, John ^d   Henry, Keith ^e   Metzler, Sara ^f   Önen, Nur ^g   Conley, Lois ^c   Wood, Kathy ^b   Brooks, John T ^c   Buchacz, Kate ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CERNER CORPORATION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Denver Infectious Disease Consultants   (United States)

^e HENNEPIN COUNTY MEDICAL CENTER   (United States)

^f MIRIAM HOSPITAL   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUDIO COMPUTER ASSISTED SELF INTERVIEW; COMPUTER ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DEPRESSION; FEMALE; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; TREATMENT OUTCOME; TREATMENT REFUSAL; UNITED STATES; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; MALE; MASS SCREENING; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES; VIRAL LOAD;

EID: 84870566774     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0132     Document Type: Article

References (61)

1. Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001;58:721-728.
2. Capron DW, Gonzalez A, Parent J, Zvolensky MJ, Schmidt NB. Suicidality and anxiety sensitivity in adults with HIV. AIDS Patient Care STDS 2012;26:298-303.
3. Centers for Disease Control and Prevention (CDC). Current depression among adults\United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep 2010;59:1229-1235.
4. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001;158:725-730.
5. Lopes M, Olfson M, Rabkin J, et al. Gender, HIV status, and psychiatric disorders: Results from the National Epidemio-logic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2012;73:384-391.
6. Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep 2008;5:163-171.
7. Atkinson JH, Heaton RK, Patterson TL, et al. Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord 2008;108:225-234.
8. Turner BJ, Fleishman JA. Effect of dysthymia on receipt of HAART by minority HIV-infected women. J Gen Intern Med 2006;21:1235-1241.
9. Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV: Who are we missing? J Gen Intern Med 2003;18:450-460.
10. Kong MC, Nahata MC, Lacombe VA, Seiber EE, Balkrishnan R. Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med 2012; 27:1159-1164.
11. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 2004;45:394-402.
12. Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002;30:401-409.
13. Farinpour R, Miller EN, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: Findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neu-ropsychol 2003;25:654-670.
14. Hartzell JD, Janke IE, Weintrob AC. Impact of depression on HIV outcomes in the HAART era. J Antimicrob Chemother 2008;62:246-255.
15. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285:1466-1474.
16. Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: A longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr 2010;53:266-272.
17. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007;21:1175-1183.
18. Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: A systematic review. AIDS Behav 2012;16:2119-2143.
19. Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. J Acquir Immune Defic Syndr 2011;58: 181-187.
20. Hartzell JD, Spooner K, Howard R, Wegner S, Wortmann G. Race and mental health diagnosis are risk factors for highly active antiretroviral therapy failure in a military cohort despite equal access to care. J Acquir Immune Defic Syndr 2007;44:411-416.
21. Miles MS, Holditch-Davis D, Pedersen C, Eron JJ, Jr., Schwartz T. Emotional distress in African American women with HIV. J Prev Interv Community 2007;33:35-50.
22. Morrison MF, Petitto JM, Ten Have T, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002;159:789-796.
23. Shacham E, Basta TB, Reece M. Symptoms of psychological distress among African Americans seeking HIV-related mental health care. AIDS Patient Care STDS 2008;22: 413-421.
24. Silverberg MJ, Jacobson LP, French AL, Witt MD, Gange SJ. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage 2009;38:197-207.
25. Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with anti-retroviral adherence in HIV-infected drug users. J Gen Intern Med 2003;18:248-257.
26. Williams DR, Gonzalez HM, Neighbors H, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: Results from the National Survey of American Life. Arch Gen Psychiatry 2007;64:305-315.
27. Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS 2012;20:418-428.
28. Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behav Med 2011;37:77-80.
29. Vyavaharkar M, Moneyham L, Corwin S, Saunders R, An-nang L, Tavakoli A. Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States. J Assoc Nurses AIDS Care 2010;21:144-152.
30. Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002;159:1752-1759.
31. Ferrando SJ, Freyberg Z. Treatment of depression in HIV positive individuals: A critical review. Int Rev Psychiatry 2008;20:61-71.
32. Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 2008;47:384-390.
33. Olatunji BO, Mimiaga MJ, O'Cleirigh C, Safren SA. Review of treatment studies of depression in HIV. Top HIV Med 2006;14:112-124.
34. Schackman BR, Dastur Z, Rubin DS, et al. Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care. AIDS Care 2009;21:992-999.
35. Walkup J, Wei W, Sambamoorthi U, Crystal S. Anti-depressant treatment and adherence to combination anti-retroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q 2008;79:43-53.
36. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to anti-retroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005;38:432-438.
37. Hooshyar D, Goulet J, Chwastiak L, et al. Time to depression treatment in primary care among HIV-infected and unin-fected veterans. J Gen Intern Med 2010;25:656-662.
38. Shacham E, Nurutdinova D, Satyanarayana V, Stamm K, Overton ET. Routine screening for depression: Identifying a challenge for successful HIV care. AIDS Patient Care STDS 2009;23:949-955.
39. Sueoka K, Goulet JL, Fiellin DA, et al. Depression symptoms and treatment among HIV infected and uninfected veterans. AIDS Behav 2010;14:272-279.
40. Crane PK, Gibbons LE, Willig JH, et al. Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9). AIDS Care 2010;22:874-885.
41. Fann JR, Berry DL, Wolpin S, et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology 2009;18:14-22.
42. Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med 2006;21:547-552.
43. Kobak KA, Taylor LH, Dottl SL, et al. A computer-administered telephone interview to identify mental disorders. JAMA 1997;278:905-910.
44. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606-613.
45. Lawrence ST, Willig JH, Crane HM, et al. Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting. Clin Infect Dis 2010;50:1165-1173.
46. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744.
47. Vellozzi C, Brooks JT, Bush TJ, et al. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study). Am J Epidemiol 2009;169: 642-652.
48. Centers for Disease Control and Prevention (CDC). Mental health in the United States: Health risk behaviors and conditions among persons with depression-New Mexico, 2003. MMWR Morb Mortal Wkly Rep 2005;54:989-991.
49. Senn TE, Carey MP, Vanable PA. The intersection of violence, substance use, depression, and STDs: Testing of a syndemic pattern among patients attending an urban STD clinic. J Natl Med Assoc 2010;102:614-620.
50. Forton DM, Taylor-Robinson SD, Thomas HC. Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2006;18:333-338.
51. Baum MK, Jayaweera DT, Duan R, et al. Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. J Addict Dis 2008;27:37-48.
52. Braitstein P, Montessori V, Chan K, et al. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort. AIDS Care 2005;17:505-515.
53. Evans DL, Staab J, Ward H, et al. Depression in the medically ill: Management considerations. Depress Anxiety 1996;4:199-208.
54. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. So-ciodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
55. Anastos K, Schneider MF, Gange SJ, et al. The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. J Acquir Immune Defic Syndr 2005;39:537-544.
56. Kyser M, Buchacz K, Bush TJ, et al. Factors Associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care 2011; 23:601-611.
57. Applebaum AJ, Richardson MA, Brady SM, Brief DJ, Keane TM. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS Behav 2009;13:60-65.
58. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapy. Drugs 2006;66:769-789.
59. Giordano TP, Bartsch G, Zhang Y, et al. Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS 2010;24:287-295.
60. Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen Hosp Psychiatry 2010;32:345-359.
61. Millett GA, Crowley JS, Koh H, et al. A way forward: The national HIV/AIDS strategy and reducing HIV incidence in the United States. JAIDS 2010;55:S144-S147.